COVID-19 vaccine Archives | Page 12 of 19 | Be Korea-savvy
1st Batch of COVID-19 Vaccines Shipped in S. Korea Ahead of Public Inoculation Program

1st Batch of COVID-19 Vaccines Shipped in S. Korea Ahead of Public Inoculation Program

SEOUL, Feb. 24 (Korea Bizwire) – Shipments of the first batch of COVID-19 vaccines for South Koreans began Wednesday as health authorities gear up to launch a public inoculation program later this week. The inaugural shipments of vaccines developed by British-Swedish pharmaceutical giant AstraZeneca were made at a drug manufacturing plant of SK Bioscience Co. [...]

S. Korea to Begin Inoculations This Week, Herd Immunity by Nov. in Question

S. Korea to Begin Inoculations This Week, Herd Immunity by Nov. in Question

SEOUL, Feb. 23 (Korea Bizwire) — South Korea will begin its first inoculations against the novel coronavirus later this week, health authorities said Tuesday, adding it might not be able to achieve herd immunity by November. The Korea Disease Control and Prevention Agency (KDCA) said it will launch the free inoculation program with British-Swedish pharmaceutical [...]

Novavax Completes Enrollment of PREVENT-19, COVID-19 Vaccine Pivotal Phase 3 Trial in the United States and Mexico

Novavax Completes Enrollment of PREVENT-19, COVID-19 Vaccine Pivotal Phase 3 Trial in the United States and Mexico

GAITHERSBURG, Md., Feb. 22 (Korea Bizwire) — Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced the complete enrollment of PREVENT-19, its pivotal Phase 3 study in the United States and Mexico to evaluate the efficacy, safety and immunogenicity of the company’s COVID-19 vaccine. Novavax has previously reported positive interim [...]

Less than Half of S. Koreans Willing to Receive COVID-19 Vaccine Shots Immediately

Less than Half of S. Koreans Willing to Receive COVID-19 Vaccine Shots Immediately

SEOUL, Feb. 22 (Korea Bizwire) — Less than half of South Koreans are willing to receive COVID-19 vaccine shots immediately, without waiting for further reports on those vaccines’ effects, an opinion poll showed Monday. In the survey conducted on 1,020 people aged 18 or over by the Korea Society Opinion Institute from last Friday to [...]

Novavax Announces Memorandum of Understanding with Gavi for Cumulative Supply to COVAX Facility of 1.1 Billion Doses of COVID-19 Vaccine

Novavax Announces Memorandum of Understanding with Gavi for Cumulative Supply to COVAX Facility of 1.1 Billion Doses of COVID-19 Vaccine

GAITHERSBURG, Md., Feb. 18 (Korea Bizwire) — Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced a Memorandum of Understanding (MOU) with Gavi, the Vaccine Alliance (Gavi), to provide 1.1 billion cumulative doses of NVX-CoV2373, Novavax’ recombinant protein-based COVID-19 vaccine candidate, for the COVAX Facility. The vaccine doses [...]

Novavax Announces Expanded Collaboration and License Agreement with SK Bioscience for 40 Million Doses of COVID-19 Vaccine for South Korea

Novavax Announces Expanded Collaboration and License Agreement with SK Bioscience for 40 Million Doses of COVID-19 Vaccine for South Korea

GAITHERSBURG, Md., Feb. 15 (Korea Bizwire) — Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, and SK Bioscience, a vaccine business subsidiary of SK Group, today announced an expanded collaboration and license agreement. In addition to the already existing manufacturing arrangement, SK Bioscience has obtained a license to manufacture and [...]